LifeStance Health Group (LFST) Stock Looks Strong On Returns Yet Stretched On Earnings

Simply Wall St.08-13

LifeStance Health Group stock has delivered a sharp 146.8% return over the past year, yet its valuation checks still flag the shares as expensive rather than a clear bargain. For investors looking at ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2659183775?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","is_english":true,"pubTime":"2026-08-13 04:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2659183775","market":"sg","top_or_hot":-1,"title":"LifeStance Health Group (LFST) Stock Looks Strong On Returns Yet Stretched On Earnings","media":"Simply Wall St.","content":"<div>\n<p>LifeStance Health Group stock has delivered a sharp 146.8% return over the past year, yet its valuation checks still flag the shares as expensive rather than a clear bargain. For investors looking at ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/lifestance-health-group-lfst-stock-looks-strong-on-returns-y\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LifeStance Health Group (LFST) Stock Looks Strong On Returns Yet Stretched On Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLifeStance Health Group (LFST) Stock Looks Strong On Returns Yet Stretched On Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-13 04:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/lifestance-health-group-lfst-stock-looks-strong-on-returns-y><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>LifeStance Health Group stock has delivered a sharp 146.8% return over the past year, yet its valuation checks still flag the shares as expensive rather than a clear bargain. For investors looking at ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/lifestance-health-group-lfst-stock-looks-strong-on-returns-y\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LFST","symbol_name":"LifeStance Health Group, Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/lifestance-health-group-lfst-stock-looks-strong-on-returns-y","article_id":"2659183775","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/lifestance-health-group-lfst-stock-looks-strong-on-returns-y","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2659183775","pubTimestamp":1786566495,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"LifeStance Health Group stock has delivered a sharp 146.8% return over the past year, yet its valuation checks still flag the shares as expensive rather than a clear bargain. For investors looking at LifeStance Health Group today, the recent gains sit alongside a low value score and a market view that the stock trades on rich multiples.\n\nLifeStance Health Group has returned 146.8% over the past 12 months, which means anyone stepping in now is doing so after a strong run.\nStronger revenue,...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"LFST":"LifeStance Health Group, Inc."},"translate_title":"LifeStance Health Group (LFST) 股票的回报看起来强劲，但盈利捉襟见肘","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFST":1.5},"content_text":"LifeStance Health Group stock has delivered a sharp 146.8% return over the past year, yet its valuation checks still flag the shares as expensive rather than a clear bargain. For investors looking at LifeStance Health Group today, the recent gains sit alongside a low value score and a market view that the stock trades on rich multiples.  LifeStance Health Group has returned 146.8% over the past 12 months, which means anyone stepping in now is doing so after a strong run. Stronger revenue, profitability and a new share repurchase program can support higher expectations for the business, while any disappointment in future growth or margins may quickly pressure what investors are willing to pay for the stock. On Simply Wall St's broader valuation checks, LifeStance Health Group is assessed as expensive on all measures, with a low value score of 0 out of 6. This points to limited evidence of obvious undervaluation.  The issue now is whether LifeStance Health Group's current share price still offers enough value after this strong run or whether expectations built into the stock have moved too far ahead of the fundamentals. LifeStance Health Group delivered 146.8% returns over the last year. See how this stacks up to the rest of the Healthcare industry. AdvertisementHas LifeStance Health Group Run Too Far on Earnings? The P/E ratio is the main focus for LifeStance Health Group because the company is now reporting positive net income that can anchor an earnings based comparison. LifeStance Health Group currently trades on a P/E of 86.8x, which sits well above the broader Healthcare industry average of 24.7x and also above the peer group average of 70.8x. That already puts the stock at a clear premium to many other healthcare providers on simple earnings terms. On Simply Wall St’s tailored fair multiple, which blends factors such as growth profile, margins, size and risk, LifeStance Health Group screens on a fair P/E closer to 42.8x. The gap between this figure and the current 86.8x indicates that the stock valuation embeds a substantial amount of positive expectations. Despite LifeStance recently reporting strong quarterly results and raising its 2026 outlook, the current P/E still sits well ahead of what this framework points to as a more grounded level. Overall, LifeStance Health Group appears expensive on its current P/E multiple compared with both tailored and industry benchmarks. NasdaqGS:LFST P/E Ratio as at Aug 2026 See what the numbers say about this price — find out in our valuation breakdown. The LifeStance Health Group Narrative: What Would Justify Today's Price? Simply Wall St Narratives pick up where the LifeStance Health Group valuation puzzle leaves off by spelling out which paths for growth, margins and earnings would need to play out for the stock to be worth materially more or less than today’s price, based on views shared on the Community page. Each narrative links its number to a specific view on how LifeStance Health Group's growth, profitability and risks might evolve, which you can revisit as new data arrives. Community views on LifeStance Health Group now sit on two very different tracks, with one camp leaning into the upside story and the other focused on the risks around execution and competition. Bull case: 12% undervalued \"LifeStance's increasingly differentiated clinician support platform, industry-leading documentation automation, and robust cash-based incentive programs position it to command outsized clinician net adds and sharply lower churn...\" Read the full Bull Case to see why LifeStance Health Group could be undervalued Bear case: 28% overvalued \"Increased competition from digital and integrated health providers, alongside clinician turnover, threatens growth in patient volume, market share, and margins...\" Read the full Bear Case to see why LifeStance Health Group could be overvalued Do you think there's more to the story for LifeStance Health Group? Head over to our Community to see what others are saying! The Bottom Line LifeStance Health Group screens as overvalued on market multiples, with the current P/E sitting well above both industry and tailored fair multiple benchmarks. That leaves less room for error if growth or margin progress falls short of what the price implies. The key question from here is whether LifeStance Health Group can deliver a level of sustainable earnings expansion that keeps investors comfortable paying this kind of premium, or whether the multiple eventually settles closer to peers.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2659183775","isCrawlerRequest":true}